Mark Faries MD
Melanoma, Surgical Oncology (Other than Breast)
Physician
Join to View Full Profile
11800 Wilshire BoulevardLos Angeles, CA 90025
Phone+1 310-231-2164
Fax+1 310-496-0731
Dr. Faries is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Faries is a general surgeon in Los Angeles, CA specializing in Surgical Oncology. He is Co-Director of Cutaneous Oncology at The Angeles Clinic and Research Institute and Professor of Surgery at Cedars-Sinai Medical Center. His clinical and translational research focuses on melanoma and other high-risk skin cancers, tumor immunology and immunotherapy and surgical therapy for cancer.
Education & Training
University of Pennsylvania Health SystemResidency, Surgery, 1996 - 2002- University of Pennsylvania Health SystemInternship, Surgery, 1995 - 1996
Weill Cornell MedicineClass of 1995
Certifications & Licensure
CA State Medical License 2002 - 2026
CT State Medical License 2010 - 2015
PA State Medical License 1996 - 2004
American Board of Surgery Surgery
Clinical Trials
- An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) Start of enrollment: 2019 Jul 18
Roles: Contact
Publications & Presentations
PubMed
- Identification of Predictive Factors for the Development of In-Transit Metastasis in Patients with Melanoma.Anne Huibers, Stanley P Leong, Mohammed Kashani-Sabet, Richard L White Jr, John Vetto
Annals of Surgical Oncology. 2025-03-10 - ASO Visual Abstract: Prognostic Value of Nevus-Associated Melanoma in Patients with Melanoma.Nazia Riaz, Anne Huibers, Stanley P Leong, Mohammed Kashani-Sabet, Richard L White Jr
Annals of Surgical Oncology. 2025-03-08 - Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II).Pia J Heino, Jukka Pappinen, John F Thompson, Micaela Hernberg, Tiina A Jahkola
Acta Oncologica. 2025-02-10
Press Mentions
Getting Under the Skin at May 11 Symposium on MelanomaMay 1st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
